Neuprex rBPI-21 bactericidal and endotoxin neutralizing agent: Began a Phase II trial in 72 patients in the Netherlands, with the primary endpoint of reducing c

XOMA Corp. (XOMA), Berkeley, Calif.
Product: Neuprex rBPI-21

Read the full 80 word article

How to gain access

Continue reading with a
two-week free trial.